FDA Aims To Be 'Nimble' On COVID-19 Vaccine Changes For Variants | NPR & Houston Public Media
/ Acting FDA Commissioner Janet Woodcock said the agency would likely hold advisory panel meetings to consider changes in COVID-19 vaccines made in response to coronavirus variants. // NPR, Scott Hensley With two COVID-19 vaccines available in the United States and more on the way, things are starting to look up. But virus mutations being detected around the world mean the vaccines may one day need updates to ensure they stay effective. The Food and Drug Administration is already working on a playbook for how it could greenlight vaccine changes. "So, we have been trying to think abou...